OncoCipherPATIENT
Educational & Guideline Reference Notice: Unranked FDA-label and national guideline option categories and recruiting clinical trials for discussion with a licensed oncologist. Protocol drug dosing and autonomous treatment prescriptions are excluded.

← Cutaneous & Mucosal Melanoma Overview

Cutaneous & Mucosal Melanoma — 32 Curated Clinical Trials

Registry Snapshot: 2026-11-15 · Table SHA-256: 7c8e2476075755e0

NCT IdentifierTitle & SponsorPhase / Status
NCT01638676A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
PHASE1/PHASE2
RECRUITING
NCT02621021A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
PHASE2
RECRUITING
NCT02830724Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
PHASE1/PHASE2
RECRUITING
NCT03567889Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
PHASE3
RECRUITING
NCT03842943Neoadjuvant Combination Immunotherapy for Stage III Melanoma
PHASE2
RECRUITING
NCT03947385Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
PHASE1/PHASE2
RECRUITING
NCT04119024Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
PHASE1
RECRUITING
NCT04511013A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
PHASE2
RECRUITING
NCT04594187Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
PHASE2
RECRUITING
NCT04787042Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
PHASE1/PHASE2
RECRUITING
NCT04844528Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
PHASE2
RECRUITING
NCT04895709A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
PHASE1/PHASE2
RECRUITING
NCT04899908Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
PHASE2
RECRUITING
NCT05098210Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
PHASE1
RECRUITING
NCT05136196BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
PHASE2
RECRUITING
NCT05144698RAPA-201 Therapy of Solid Tumors
PHASE1/PHASE2
RECRUITING
NCT05155033Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
PHASE2
RECRUITING
NCT05267626Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
PHASE1/PHASE2
RECRUITING
NCT05280314Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
PHASE2
RECRUITING
NCT05384496Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
PHASE2
RECRUITING
NCT05428007Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
PHASE2
RECRUITING
NCT05546827Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma
PHASE2
RECRUITING
NCT05549297Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
PHASE3
RECRUITING
NCT05588453Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
PHASE1/PHASE2
RECRUITING
NCT05607095A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
PHASE1
RECRUITING
NCT05655312MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
PHASE1/PHASE2
RECRUITING
NCT05704647Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
PHASE2
RECRUITING
NCT05727904Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
PHASE3
RECRUITING
NCT05779423Cryoablation+Ipilimumab+Nivolumab in Melanoma
PHASE2
RECRUITING
NCT05830058Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
PHASE2
RECRUITING
NCT05877430Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
PHASE1/PHASE2
RECRUITING
NCT05896839Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
PHASE1/PHASE2
RECRUITING